When was Hemab Therapeutics Holdings's last funding round?

Hemab Therapeutics Holdings's most recent recorded round was Later Stage VC (Series C) in Oct 2025, raising $157.0M.

PrivateMarketView

How much has Hemab Therapeutics Holdings raised?

$355.1Macross 2 recorded rounds · Feb 2023 – Oct 2025

Most recently, Hemab Therapeutics Holdings raised $157.0M in its Later Stage VC (Series C) (Oct 2025).

Free account

More of Hemab Therapeutics Holdings with a free account

No card required

Membership and data by Private Market View

2 rounds

Oct 2025Later Stage VC (Series C)$157.0M▮

+ 1 more investors · free account

Feb 2023Early Stage VC (Series B)$137.8M▮

+ 1 more investors · free account

Hemab Therapeutics Holdings has raised $355 million across 2 recorded rounds since 2023. The largest was a $157 million Series C in Oct 2025.

12 investors are on record for Hemab Therapeutics Holdings, including RA Capital Management, Novo Holdings, Sofinnova Partners and The Invus Group. The Series C in Oct 2025 drew 10 investors.

For fundraisers

Raising for a company like Hemab Therapeutics Holdings?

12 investors have backed Hemab Therapeutics Holdings — start your target list with the firms already writing checks in drug discovery.

How much has Hemab Therapeutics Holdings raised?: Hemab Therapeutics Holdings has raised $355.1M in total across 2 recorded funding rounds.
When was Hemab Therapeutics Holdings's last funding round?: Hemab Therapeutics Holdings's most recent recorded round was Later Stage VC (Series C) in Oct 2025, raising $157.0M.